Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
15 03 2020
Historique:
received: 02 04 2019
revised: 21 06 2019
accepted: 04 07 2019
pubmed: 22 7 2019
medline: 15 2 2020
entrez: 21 7 2019
Statut: ppublish

Résumé

Cervical cancer remains a significant cause of morbidity and mortality in women worldwide and is the leading cause of cancer-related death in Botswana. It is well established that women with HIV have a higher risk of persistent HPV infection leading to cervical cancer. We assessed HPV prevalence and genotype distribution in 126 tissue specimens from confirmed invasive cervical cancer cases using Abbott real-time PCR assay. Overall, 88 (69.8%) women were HIV-infected. Fifty-seven (64.8%) of the HIV-infected women had a baseline CD4

Identifiants

pubmed: 31325316
doi: 10.1002/ijc.32581
pmc: PMC7055961
mid: NIHMS1553489
doi:

Substances chimiques

Anti-HIV Agents 0
DNA, Viral 0
Papillomavirus Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1667-1673

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI073141
Pays : United States
Organisme : Wellcome Trust
ID : 107752/Z/15/Z
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : U54 CA190158
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI045008
Pays : United States
Organisme : Conquer Cancer Foundation Young Investigator Award, and Penn Center for AIDS Research
ID : 5-P30-AI-045008-17
Pays : International
Organisme : NCI NIH HHS
ID : K08 CA230170
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : K01 AI118559
Pays : United States

Informations de copyright

© 2019 UICC.

Références

Int J Gynecol Pathol. 2011 Nov;30(6):591-6
pubmed: 21979597
J Med Virol. 2011 Oct;83(10):1689-95
pubmed: 21837784
Infect Agent Cancer. 2014 Jul 08;9:22
pubmed: 25053972
J Clin Pathol. 2002 Apr;55(4):244-65
pubmed: 11919208
J Infect Dis. 2011 Apr 1;203(7):910-20
pubmed: 21402543
Appl Biochem Biotechnol. 2014 Jan;172(1):188-95
pubmed: 24057351
Lancet Oncol. 2009 Apr;10(4):321-2
pubmed: 19350698
Virology. 2010 May 25;401(1):70-9
pubmed: 20206957
Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):201-210
pubmed: 29619965
Open AIDS J. 2016 Apr 08;10:34-48
pubmed: 27347270
Gynecol Oncol. 2008 Sep;110(3 Suppl 2):S4-7
pubmed: 18760711
J Natl Cancer Inst. 2003 Jul 16;95(14):1062-71
pubmed: 12865452
Acta Dermatovenerol Alp Pannonica Adriat. 2013;22(2):43-7
pubmed: 23836358
Methods Mol Biol. 2011;665:195-212
pubmed: 21116803
MethodsX. 2018 May 31;5:569-578
pubmed: 29992095
J Clin Oncol. 2016 Nov 1;34(31):3749-3757
pubmed: 27573661
Br J Cancer. 2012 Oct 23;107(9):1624-30
pubmed: 23033006
Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):503-10
pubmed: 20142247
Am J Prev Med. 2014 Mar;46(3 Suppl 1):S7-15
pubmed: 24512933
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1274-80
pubmed: 16835323
Lancet Oncol. 2010 Nov;11(11):1048-56
pubmed: 20952254
Int J Cancer. 2011 Feb 15;128(4):927-35
pubmed: 20473886
J Med Virol. 2007 Jun;79(6):758-65
pubmed: 17457908
Int J Cancer. 2002 Nov 20;102(3):237-43
pubmed: 12397642
J Clin Microbiol. 2002 Sep;40(9):3341-5
pubmed: 12202576
J Med Virol. 2015 Mar;87(3):504-7
pubmed: 25331595
J Clin Invest. 2016 Jan;126(1):5-11
pubmed: 26727228
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):332-339
pubmed: 27331659
Infect Agent Cancer. 2016 Nov 11;11:56
pubmed: 27843487
Vaccine. 2006 Aug 31;24 Suppl 3:S3/35-41
pubmed: 16950016
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Adolesc Health. 2011 May;48(5):473-80
pubmed: 21501806
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482
Curr Biol. 2012 Sep 11;22(17):R741-52
pubmed: 22975005

Auteurs

Leabaneng Tawe (L)

Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Emily MacDuffie (E)

Warren Alpert Medical School of Brown University, Providence, RI.

Mohan Narasimhamurthy (M)

Department of Pathology, Faculty of Medicine, University of Botswana, Gaborone, Botswana.

Qiao Wang (Q)

Sue & Bill Gross School of Nursing, University of California Irvine, Irvine, CA.

Simani Gaseitsiwe (S)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA.

Sikhulile Moyo (S)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA.

Ishmael Kasvosve (I)

Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.

Sanghyuk S Shin (SS)

Sue & Bill Gross School of Nursing, University of California Irvine, Irvine, CA.

Nicola M Zetola (NM)

Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.

Giacomo M Paganotti (GM)

Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Surbhi Grover (S)

Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH